Endocrine resistance and epigenetic reprogramming in estrogen receptor positive breast cancer
出版年份 2021 全文链接
标题
Endocrine resistance and epigenetic reprogramming in estrogen receptor positive breast cancer
作者
关键词
Endocrine resistance, Epigenetics, Methylation, Histone modifications, ncRNA
出版物
CANCER LETTERS
Volume 517, Issue -, Pages 55-65
出版商
Elsevier BV
发表日期
2021-05-30
DOI
10.1016/j.canlet.2021.05.030
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer
- (2020) Joanna Achinger-Kawecka et al. Nature Communications
- Overcoming Endocrine Resistance in Breast Cancer
- (2020) Ariella B. Hanker et al. CANCER CELL
- LncRNA LINP1 confers tamoxifen resistance and negatively regulated by ER signaling in breast cancer
- (2020) Tingting Ma et al. CELLULAR SIGNALLING
- Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
- (2020) William J. Gradishar et al. Journal of the National Comprehensive Cancer Network
- Comprehensive Transcriptomic Analysis Reveals Dysregulated Competing Endogenous RNA Network in Endocrine Resistant Breast Cancer Cells
- (2020) Liang Gao et al. Frontiers in Oncology
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Epigenetic biomarker screening by FLIM-FRET for combination therapy in ER+ breast cancer
- (2019) Wenjie Liu et al. Clinical Epigenetics
- Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer
- (2019) Helai P. Mohammad et al. NATURE MEDICINE
- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dual Epigenetic Regulation of ERα36 Expression in Breast Cancer Cells
- (2019) Charlène Thiebaut et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer
- (2019) Yuting Sang et al. MOLECULAR THERAPY
- Fulvestrant in the treatment of hormone receptor‐positive/human epidermal growth factor receptor 2‐negative advanced breast cancer: A review
- (2019) Junjie Li et al. Cancer Medicine
- CircRNA_0025202 regulates tamoxifen sensitivity and tumor progression via regulating the miR-182-5p/FOXO3a axis in breast cancer
- (2019) Yuting Sang et al. Molecular Therapy-Nucleic Acids
- Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy
- (2019) Aradhana Rani et al. Frontiers in Endocrinology
- Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2019) F Cardoso et al. ANNALS OF ONCOLOGY
- The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy
- (2019) Ji Wang et al. Journal of Hematology & Oncology
- LINC00309 is associated with short disease-free survival in breast cancer
- (2019) Sheng Huang et al. Cancer Cell International
- ESR1-stabilizing lncRNA TMPO-AS1 promotes hormone-refractory breast cancer progression
- (2019) Yuichi Mitobe et al. MOLECULAR AND CELLULAR BIOLOGY
- Breast cancer
- (2019) Nadia Harbeck et al. Nature Reviews Disease Primers
- Pathways to Endocrine Therapy Resistance in Breast Cancer
- (2019) Md. Moquitul Haque et al. Frontiers in Endocrinology
- Epigenetic silencing of SALL 2 confers tamoxifen resistance in breast cancer
- (2019) Liping Ye et al. EMBO Molecular Medicine
- Differential microRNA profiles between fulvestrant-resistant and tamoxifen-resistant human breast cancer cells
- (2018) Qian Zhou et al. ANTI-CANCER DRUGS
- Downregulation of lncRNA GAS5 confers tamoxifen resistance by activating miR-222 in breast cancer
- (2018) Juan Gu et al. CANCER LETTERS
- Aromatase inhibitors in premenopausal women with breast cancer: the state of the art and future prospects
- (2018) M. Pistelli et al. Current Oncology
- Altered DNA methyltransferases promoter methylation and mRNA expression are associated with tamoxifen response in breast tumors
- (2018) Rosa Jahangiri et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer
- (2018) Darren K. Patten et al. NATURE MEDICINE
- KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function
- (2018) Kinisha Gala et al. ONCOGENE
- Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment
- (2018) Hitisha K. Patel et al. PHARMACOLOGY & THERAPEUTICS
- Association of microRNA-7 and its binding partner CDR1-AS with the prognosis and prediction of 1st-line tamoxifen therapy in breast cancer
- (2018) K. Uhr et al. Scientific Reports
- microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
- (2018) Erin W. Howard et al. BIOLOGICAL PROCEDURES ONLINE
- The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
- (2018) Pedram Razavi et al. CANCER CELL
- Personalizing aromatase inhibitor therapy in patients with breast cancer
- (2018) Issam S. Hamadeh et al. CANCER TREATMENT REVIEWS
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
- (2018) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Aberrant expression of SETD1A promotes survival and migration of estrogen receptor α-positive breast cancer cells
- (2018) Ming Li Jin et al. INTERNATIONAL JOURNAL OF CANCER
- LncRNA DSCAM-AS1 acts as a sponge of miR-137 to enhance Tamoxifen resistance in breast cancer
- (2018) Yun Ma et al. JOURNAL OF CELLULAR PHYSIOLOGY
- KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance
- (2018) Kunihiko Hinohara et al. CANCER CELL
- The cancer epigenome: Concepts, challenges, and therapeutic opportunities
- (2017) Mark A. Dawson SCIENCE
- Silencing of MicroRNA-21 confers the sensitivity to tamoxifen and fulvestrant by enhancing autophagic cell death through inhibition of the PI3K-AKT-mTOR pathway in breast cancer cells
- (2016) Xinfeng Yu et al. BIOMEDICINE & PHARMACOTHERAPY
- Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer
- (2016) Didier Meseure et al. BRITISH JOURNAL OF CANCER
- Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes
- (2016) Junjian Wang et al. CANCER LETTERS
- FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance
- (2016) Y Yu-Rice et al. ONCOGENE
- Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer
- (2016) Nai-si Huang et al. Oncotarget
- Human Steroid Biosynthesis for the Oncologist
- (2016) Mary Louise Auchus et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/β-Catenin Pathway
- (2016) Hongying Liu et al. PLoS One
- Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer
- (2015) Zhike Chen et al. BREAST CANCER RESEARCH AND TREATMENT
- Noncoding RNAs in breast cancer
- (2015) Pang-Kuo Lo et al. Briefings in Functional Genomics
- Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER− breast cancer cell lines
- (2015) Qian Wu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Oral Selective Estrogen Receptor Downregulators (SERDs), a Breakthrough Endocrine Therapy for Breast Cancer
- (2015) Donald P. McDonnell et al. JOURNAL OF MEDICINAL CHEMISTRY
- LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer
- (2015) X Xue et al. ONCOGENE
- DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer
- (2015) Andrew Stone et al. Nature Communications
- A Role for Histone H2B Variants in Endocrine-Resistant Breast Cancer
- (2015) Shweta R Nayak et al. Hormones & Cancer
- Promoting E2F1-mediated apoptosis in oestrogen receptor-α-negative breast cancer cells
- (2014) María F Montenegro et al. BMC CANCER
- Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells
- (2014) Yifang Wei et al. BREAST CANCER RESEARCH AND TREATMENT
- JARID1B Is a Luminal Lineage-Driving Oncogene in Breast Cancer
- (2014) Shoji Yamamoto et al. CANCER CELL
- An epigenomic approach to therapy for tamoxifen-resistant breast cancer
- (2014) Qin Feng et al. CELL RESEARCH
- ACK1 Tyrosine Kinase Interacts with Histone Demethylase KDM3A to Regulate the Mammary Tumor Oncogene HOXA1
- (2014) Kiran Mahajan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epigenetic Reprogramming of HOXC10 in Endocrine-Resistant Breast Cancer
- (2014) T. N. Pathiraja et al. Science Translational Medicine
- Long Noncoding RNAs: Past, Present, and Future
- (2013) J. T. Y. Kung et al. GENETICS
- Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor
- (2013) Denise A. Yardley et al. JOURNAL OF CLINICAL ONCOLOGY
- The future of epigenetic therapy in solid tumours—lessons from the past
- (2013) Nilofer Azad et al. Nature Reviews Clinical Oncology
- Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer
- (2013) L. Magnani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Estrogen and Cancer
- (2012) Jing Liang et al. Annual Review of Physiology
- Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
- (2012) Christina Davies et al. LANCET
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer
- (2011) P N Munster et al. BRITISH JOURNAL OF CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
- (2011) Walter L. Miller et al. ENDOCRINE REVIEWS
- Estrogen Carcinogenesis in Breast Cancer
- (2011) Doris Germain ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Scriptaid effects on breast cancer cell lines
- (2011) L. Giacinti et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Molecular Mechanisms of Long Noncoding RNAs
- (2011) Kevin C. Wang et al. MOLECULAR CELL
- The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells
- (2010) Selma Masri et al. BREAST CANCER RESEARCH AND TREATMENT
- Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer
- (2010) M F E Godinho et al. BRITISH JOURNAL OF CANCER
- Histological types of breast cancer: How special are they?
- (2010) Britta Weigelt et al. Molecular Oncology
- MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways
- (2010) X Rao et al. ONCOGENE
- miR-22 Inhibits Estrogen Signaling by Directly Targeting the Estrogen Receptor mRNA
- (2009) D. P. Pandey et al. MOLECULAR AND CELLULAR BIOLOGY
- Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells
- (2009) Nalinie S. Wickramasinghe et al. NUCLEIC ACIDS RESEARCH
- Regulation of Estrogenic Effects by Beclin 1 in Breast Cancer Cells
- (2008) S. John et al. CANCER RESEARCH
- MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
- (2008) Tyler E. Miller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ERα negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor
- (2008) Jiang Fan et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Transient cyclical methylation of promoter DNA
- (2008) Sara Kangaspeska et al. NATURE
- Tamoxifen: Catalyst for the change to targeted therapy
- (2007) V. Craig Jordan EUROPEAN JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started